Physician
Gynecologic Oncology
Gynecologic Oncology
OAK LAWN, IL
ADVOCATE TRINITY HOSPITAL
care.advocatehealth.com/locations/advocate-trinity-hospital-chicago
Based on specialty. Actual services may vary — contact the provider's office to confirm.
Based on CMS Medicare Provider Utilization data for 2023. These represent what this physician charged Medicare, not necessarily what you would pay. Compare with other physicians
| Procedure | Avg Charge | Medicare Allowed | Medicare Paid | Services |
|---|---|---|---|---|
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | $1,444 | $92 | $73 | 732 |
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | $750 | $182 | $141 | 33 |
96413 Administration of chemotherapy into vein, 1 hour or less | $686 | $136 | $106 | 215 |
99204 New patient office or other outpatient visit, 45-59 minutes | $620 | $175 | $127 | 27 |
99215 Established patient office or other outpatient visit, 40-54 minutes | $530 | $187 | $148 | 145 |
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | $510 | $137 | $101 | 13 |
99214 Established patient office or other outpatient visit, 30-39 minutes | $400 | $132 | $101 | 140 |
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $380 | $124 | $99 | 34 |
96417 Administration of additional new drug or substance into vein, 1 hour or less | $334 | $67 | $53 | 129 |
J9045 Injection, carboplatin, 50 mg | $300 | $2 | $2 | 816 |
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $270 | $83 | $66 | 32 |
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | $166 | $28 | $22 | 1,674 |
96415 Administration of chemotherapy into vein, each additional hour | $156 | $29 | $23 | 136 |
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | $152 | $30 | $23 | 184 |
J9271 Injection, pembrolizumab, 1 mg | $147 | $54 | $43 | 13,400 |
J2469 Injection, palonosetron hcl, 25 mcg | $122 | $1 | $1 | 800 |
96523 Irrigation of implanted venous access drug delivery device | $111 | $26 | $21 | 46 |
96375 Injection of additional new drug or substance into vein | $105 | $16 | $12 | 231 |
96377 Application of on-body injector for under skin injection | $49 | $19 | $15 | 59 |
J3490 Unclassified drugs | $9 | $1 | $1 | 59 |
J1200 Injection, diphenhydramine hcl, up to 50 mg | $7 | $1 | $1 | 84 |
J3475 Injection, magnesium sulfate, per 500 mg | $6 | $1 | $1 | 172 |
J2405 Injection, ondansetron hydrochloride, per 1 mg | $3 | $0 | $0 | 368 |
J1100 Injection, dexamethasone sodium phosphate, 1 mg | $2 | $0 | $0 | 2,422 |
J9267 Injection, paclitaxel, 1 mg | $2 | $0 | $0 | 14,852 |
Search published hospital rates side by side to find lower cash prices and stronger negotiating leverage.
Physician identity data from the NPPES NPI Registry. Last synced 3/28/2026.